sutures newsletter


FDA Warns of Gilenya Risk, Name Confusion, Looks Into GBCA Use

Pharmacy Focus

The U.S. Food and Drug Administration has issued warnings regarding the multiple sclerosis drug Gilenya and about reports of confusion between the names of the antidepressant Brintellix and anti-clotting drug Brilinta. Also, the agency is investigating the risk of brain deposits following repeated use of gadolinium-based contrast agents for magnetic resonance imaging.

Mark Your Calendar

Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.

Grand Rounds

Click here to view a schedule of all upcoming grand rounds.

Education Schedule

Click the PDF link below to see the Department of Surgery's education schedule.

Education Schedule - August 2015 (PDF)

Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Liver Transplant Program Grows

By Irene K. Kim, MD

The Cedars-Sinai Comprehensive Transplant Center (CTC) is pleased to announce some exciting changes in the Liver Transplant Program aimed at expansion of services and investment in new research initiatives.

Nicholas Nissen, MD, director of the highly regarded Hepatobiliary Surgery Program, was recently named surgical director of the Liver Transplant Program. Nissen is widely recognized as a superb hepatobiliary and pancreas surgeon. He will work closely with Tram Tran, MD, medical director of the Liver Transplant Program, to grow the Hepatology, Liver Transplant and Hepatobiliary Surgery programs at Cedars-Sinai. A core element of this growth will be the development of outreach and education services spearheaded by Kristen Cisneros.

Despite the relative paucity of transplantable livers relative to recipients in need of organ replacement in this geographical area, 46 liver transplants were successfully performed last year at Cedars-Sinai, including two heart/liver transplants and five heart/kidney transplants. Our patient survival rates are the best in Los Angeles, with 93 percent of liver transplant recipients alive one year after surgery.

Nonetheless, we believe that our team has an opportunity to expand its services, and as an institution, Cedars-Sinai is firmly committed to supporting this growth. Andrew Klein, MD, director of the CTC, in collaboration with the departments of Medicine and Surgery, has recruited two very talented individuals in hepatology and transplant surgery.

The Hepatology Division welcomes Mazen Nourredin, MD, whose research focuses on fatty liver disease and nonalcoholic steatohepatitis. Nourredin will lead new research initiatives and clinical trials centered on the treatment of fatty liver disease. Given Nourredin's expertise and additional research collaborations with our Department of Hospital Epidemiology, Cedars-Sinai will be at the forefront of the one the most rapidly growing causes of end-stage liver disease.

In the Transplant Division, Tsuyoshi Todo, MD, who completed his general surgery residency at Cedars-Sinai, has been recruited to join the full-time faculty. After finishing his fellowship in abdominal transplantation at Stanford University, Todo was pursued by a number of top transplant programs. He is a talented surgeon as well as a thoughtful investigator who has demonstrated his ability as an independent investigator through prior collaborations with our transplant immunobiology lab.

Lastly, Irene Kim, MD, was named director of the Abdominal Transplant Fellowship, which includes certification in liver transplant, kidney transplant and hepatobiliary surgery.

Cedars-Sinai is committed to training the next generation of transplant and hepatobiliary surgeons and is one of the few transplant training programs certified by the American Society of Transplant Surgeons that offers liver and kidney transplant in combination with hepatobiliary surgery accreditation.

These initiatives in liver disease and liver surgery build on the already tight-knit team of physicians, transplant coordinators, pharmacists, nurses, nurse practitioners, physician assistants and researchers who are all dedicated to one of the most complex and challenging disease processes, end-stage liver disease.

Please feel free to contact Kristen Cisneros with your questions or comments at 310-967-7024 (ext. 7-7024).

Irene K. Kim, MD, is a surgeon in the Cedars-Sinai Comprehensive Transplant Center.